Potential drug leads for SARS-CoV2 from phytochemicals of Aerva lanata: a Machine Learning approach

被引:2
|
作者
Sherin D.R. [1 ]
Sharanya N. [1 ]
Manojkumar T.K. [1 ]
机构
[1] School of Digital Sciences, Kerala University of Digital Sciences, Innovation and Technology, Thiruvananthapuram
关键词
Aerva lanata; Docking; Machine learning; SARS-CoV-2;
D O I
10.1007/s13337-021-00732-0
中图分类号
学科分类号
摘要
COVID-19 outbreak is the recently reported worldwide pandemic threat. As part of our interventions with machine learning and molecular simulation approaches, we report the inhibitory effect of thirty compounds reported from the sacred plant Aerva lanata. The predicted activity of the screened ligands are comparable with the one of the present medication, hydroxy chloroquine (HCQ), on the main protease (PDB:6YB7) of SARS-CoV-2. Our studies pointed out the effectiveness of the plant with twenty seven compounds having potential activity against the main protease compared to the reference HCQ. The robustness of some of the phytochemicals such as ervoside, which is only present in Aerva lanata computed to have very high anticoronavirus activity. The results are indicative of potential natural antivirus source, which subsidizes in thwarting the invasion of coronavirus into the human body. Many phytochemicals which are computed to be effective towards SARS-CoV-2 in this study are used as drugs for various other diseases. Perhaps these compounds could be attractive for the management of COVID-19, but clinical trials must be performed in order to validate this observation. © 2021, Indian Virological Society.
引用
收藏
页码:757 / 765
页数:8
相关论文
共 50 条
  • [21] Rerouting therapeutic peptides and unlocking their potential against SARS-CoV2
    Prashar, Namrata
    Mohammed, Saharuddin Bin
    Raja, N. S.
    Mohideen, Habeeb Shaik
    3 BIOTECH, 2025, 15 (05)
  • [22] 17β-Estradiol, a potential ally to alleviate SARS-CoV2 infection
    Breithaupt-Faloppa, Ana Cristina
    Correia, Cristiano de Jesus
    Prado, Carla Maximo
    Stilhano, Roberta Sessa
    Ureshino, Rodrigo Portes
    Pinho Moreira, Luiz Felipe
    CLINICS, 2020, 75 : 1 - 8
  • [23] Exploring potential inhibitor of SARS-CoV2 replicase from FDA approved drugs using insilico drug discovery methods
    Chandra, Anshuman
    Gurjar, Vaishali
    Ahmed, Mohammad Z.
    Alqahtani, Ali S.
    Qamar, Imteyaz
    Singh, Nagendra
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (12): : 5507 - 5514
  • [24] Bioinformatics approach to identify the influences of SARS-COV2 infections on atherosclerosis
    Zhang, Jiuchang
    Zhang, Liming
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [25] Prediction of potential inhibitors of the dimeric SARS-CoV2 main proteinase through the MM/GBSA approach
    Bello, Martiniano
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2020, 101
  • [26] Breast Cancer and SARS-Cov2: Lessons from a Pandemic
    Gosset, Marie
    Gal, Jocelyn
    Schiappa, Renaud
    Helwig, Christopher
    Bonomo, Iris
    Delpech, Yann
    Barranger, Emmanuel
    ANTICANCER RESEARCH, 2023, 43 (05) : 2235 - 2241
  • [27] A review of SARS-CoV-2 drug repurposing: databases and machine learning models
    Elkashlan, Marim
    Ahmad, Rahaf M.
    Hajar, Malak
    Al Jasmi, Fatma
    Corchado, Juan Manuel
    Nasarudin, Nurul Athirah
    Mohamad, Mohd Saberi
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [28] RNA dependent RNA polymerase (RdRp) as a drug target for SARS-CoV2
    Mishra, Avinash
    Rathore, Anurag S.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (13): : 6039 - 6051
  • [29] Characteristics of SARS-CoV2 that may be useful for nanoparticle pulmonary drug delivery
    Rabiei, Morteza
    Kashanian, Soheila
    Samavati, Seyedeh Sabereh
    Derakhshankhah, Hossein
    Jamasb, Shahriar
    McInnes, Steven J. P.
    JOURNAL OF DRUG TARGETING, 2022, 30 (03) : 233 - 243
  • [30] Decreasing Potential Risk of Transfusion Transmitted Sars-CoV2 to Cancer Patients
    Moreira Lemos, Marta Maria
    Riegel, Eduardo Ernesto
    Gomes de Molla, Raissa Pavoni
    Colella, Marina Pereira
    Colella, Marcos Paulo
    Kayano, Sandra Satoe
    Colella, Rafael
    TRANSFUSION, 2020, 60 : 99A - 100A